Clinical Trial Update: A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a topical nitroglycerin versus placebo for treatment and prevention of Raynaud's phenomenon; the trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Disease
• Raynaud Disease Secondary to Other Autoimmune Disease
• Raynaud Disease Secondary to Scleroderma

Drugs mentioned

• Nitroglycerin (topical) (nitroglycerin)

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma | Phase 3 | Status: UNKNOWN